These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices. Jonasch E; Signorovitch JE; Lin PL; Liu Z; Culver K; Pal SK; Scott JA; Vogelzang NJ Curr Med Res Opin; 2014 Oct; 30(10):2041-50. PubMed ID: 24983741 [TBL] [Abstract][Full Text] [Related]
46. Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma. Elfiky AA; Cho DC; McDermott DF; Rosenberg JE; Fortner B; Antràs L; Chen K; Sheng Duh M; Jayawant SS; Oh WK; Atkins MB; Choueiri TK Urol Oncol; 2011; 29(6):756-63. PubMed ID: 20451414 [TBL] [Abstract][Full Text] [Related]
47. Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinoma. Ayllon J; Beuselinck B; Morel A; Barrascout E; Medioni J; Scotte F; Oudard S Cancer Invest; 2011 May; 29(4):282-5. PubMed ID: 21469976 [TBL] [Abstract][Full Text] [Related]
48. Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. Deprimo SE; Bello CL; Smeraglia J; Baum CM; Spinella D; Rini BI; Michaelson MD; Motzer RJ J Transl Med; 2007 Jul; 5():32. PubMed ID: 17605814 [TBL] [Abstract][Full Text] [Related]
50. Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey. Yildiz I; Sen F; Basaran M; Ekenel M; Agaoglu F; Darendeliler E; Tunc HM; Ozcan F; Bavbek S Jpn J Clin Oncol; 2011 Dec; 41(12):1380-7. PubMed ID: 22013228 [TBL] [Abstract][Full Text] [Related]
51. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. Coppin C; Kollmannsberger C; Le L; Porzsolt F; Wilt TJ BJU Int; 2011 Nov; 108(10):1556-63. PubMed ID: 21952069 [TBL] [Abstract][Full Text] [Related]